Absence of Ras Mutations and Low Incidence of P53 Mutations in Renal Cell Carcinomas Induced by Ferric Nitrilotriacetate

Overview

Journal Jpn J Cancer Res

Specialty Oncology

Date 1995 Dec 1

PMID 8636002

Citations 3

Authors

T Akiyama

S Hamazaki

S Okada

Affiliations

Soon will be listed here.

Abstract

Renal cell carcinomas induced in male Wistar rats by iron chelate of nitrilotriacetate (Fe-NTA) were examined for mutations in ras oncogenes and p53 tumor suppressor gene. Fourteen primary tumors and two metastatic tumors from 11 animals were evaluated. Exons 1 and 2 of the H-, K-, and N-ras genes were amplified by polymerase chain reaction (PCR), and the presence of mutations was examined by direct sequencing. Exon 5 through exon 7 of p53 gene, including the 3' half of the conserved region II and the entire conserved region III through V, were surveyed for point mutations by PCR-single stranded conformation polymorphism (SSCP) analysis. Direct sequencing of the ras genes showed no mutations in codon 12, 13, or 61 among the tumors evaluated. SSCP analysis of p53 gene exon 6 indicated conformational changes in two primary tumors. One tumor had a CCG-to-CTG transition at codon 199, and the other had an ATC-to-att transition at codon 229 and two nonsense C-to-T transitions. These results suggest that neither ras genes nor p53 gene play a major role in the development of renal cell carcinomas induced by Fe-NTA.

Citing Articles

The Role of Ferric Nitrilotriacetate in Renal Carcinogenesis and Cell Death: From Animal Models to Clinical Implications.

Okazaki Y Cancers (Basel). 2022; 14(6).

PMID: 35326646 PMC: 8946552. DOI: 10.3390/cancers14061495.

Curcumin attenuates oxidative damage in animals treated with a renal carcinogen, ferric nitrilotriacetate (Fe-NTA): implications for cancer prevention.

Iqbal M, Okazaki Y, Okada S Mol Cell Biochem. 2009; 324(1-2):157-64.

PMID: 19165575 DOI: 10.1007/s11010-008-9994-z.

Prevention by 2-mercaptoethane sulfonate and N-acetylcysteine of renal oxidative damage in rats treated with ferric nitrilotriacetate.

Umemura T, Hasegawa R, Nishikawa A, Furukawa F, Toyokuni S, Uchida K Jpn J Cancer Res. 1996; 87(9):882-6.

PMID: 8878448 PMC: 5921195. DOI: 10.1111/j.1349-7006.1996.tb02115.x.

References

Morita R, Saito S, Ishikawa J, Ogawa O, Yoshida O, Yamakawa K . Common regions of deletion on chromosomes 5q, 6q, and 10q in renal cell carcinoma. Cancer Res. 1991; 51(21):5817-20. View

Tsutsumi M, Murakami Y, Kondoh S, Tsujiuchi T, Hohnoki K, Horiguchi K . Comparison of K-ras oncogene activation in pancreatic duct carcinomas and cholangiocarcinomas induced in hamsters by N-nitrosobis(2-hydroxypropyl)amine. Jpn J Cancer Res. 1993; 84(9):956-60. PMC: 5919290. DOI: 10.1111/j.1349-7006.1993.tb00184.x. View

Umemura T, Sai K, Takagi A, Hasegawa R, Kurokawa Y . Formation of 8-hydroxydeoxyguanosine (8-OH-dG) in rat kidney DNA after intraperitoneal administration of ferric nitrilotriacetate (Fe-NTA). Carcinogenesis. 1990; 11(2):345-7. DOI: 10.1093/carcin/11.2.345. View

Greenblatt M, BENNETT W, Hollstein M, Harris C . Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 1994; 54(18):4855-78. View

Tokusashi Y, Fukuda I, Ogawa K . Absence of p53 mutations and various frequencies of Ki-ras exon 1 mutations in rat hepatic tumors induced by different carcinogens. Mol Carcinog. 1994; 10(1):45-51. DOI: 10.1002/mc.2940100108. View

Nanus D, Mentle I, Motzer R, Bander N, Albino A . Infrequent ras oncogene point mutations in renal cell carcinoma. J Urol. 1990; 143(1):175-8. DOI: 10.1016/s0022-5347(17)39905-6. View

Toyokuni S, Okada S, Hamazaki S, Minamiyama Y, Yamada Y, Liang P . Combined histochemical and biochemical analysis of sex hormone dependence of ferric nitrilotriacetate-induced renal lipid peroxidation in ddY mice. Cancer Res. 1990; 50(17):5574-80. View

Halliwell B, Aruoma O . DNA damage by oxygen-derived species. Its mechanism and measurement in mammalian systems. FEBS Lett. 1991; 281(1-2):9-19. DOI: 10.1016/0014-5793(91)80347-6. View

Lubinski J, Hadaczek P, Podolski J, Toloczko A, Sikorski A, McCue P . Common regions of deletion in chromosome regions 3p12 and 3p14.2 in primary clear cell renal carcinomas. Cancer Res. 1994; 54(14):3710-3. View

10.

Koshiba M, Ogawa K, Hamazaki S, Sugiyama T, Ogawa O, Kitajima T . The effect of formalin fixation on DNA and the extraction of high-molecular-weight DNA from fixed and embedded tissues. Pathol Res Pract. 1993; 189(1):66-72. DOI: 10.1016/S0344-0338(11)80118-4. View

11.

Kasai H, Nishimura S . Hydroxylation of deoxyguanosine at the C-8 position by ascorbic acid and other reducing agents. Nucleic Acids Res. 1984; 12(4):2137-45. PMC: 318646. DOI: 10.1093/nar/12.4.2137. View

12.

Kanjilal S, Pierceall W, Cummings K, Kripke M, Ananthaswamy H . High frequency of p53 mutations in ultraviolet radiation-induced murine skin tumors: evidence for strand bias and tumor heterogeneity. Cancer Res. 1993; 53(13):2961-4. View

13.

McBRIDE T, Preston B, Loeb L . Mutagenic spectrum resulting from DNA damage by oxygen radicals. Biochemistry. 1991; 30(1):207-13. DOI: 10.1021/bi00215a030. View

14.

Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T . Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci U S A. 1989; 86(8):2766-70. PMC: 286999. DOI: 10.1073/pnas.86.8.2766. View

15.

Habuchi T, Takahashi R, Yamada H, Ogawa O, Kakehi Y, Ogura K . Influence of cigarette smoking and schistosomiasis on p53 gene mutation in urothelial cancer. Cancer Res. 1993; 53(16):3795-9. View

16.

Matsumoto K, Tsuda H, Iwase T, Ito M, Nishida Y, Oyama F . Absence of ras family point mutations at codons 12, 13 and 61 in N-ethyl-N-hydroxyethylnitrosamine- or N-nitrosomorpholine-induced renal cell tumors in rats. Jpn J Cancer Res. 1992; 83(9):933-6. PMC: 5918969. DOI: 10.1111/j.1349-7006.1992.tb02003.x. View

17.

Kobayashi T, Hirayama Y, Kobayashi E, Kubo Y, Hino O . A germline insertion in the tuberous sclerosis (Tsc2) gene gives rise to the Eker rat model of dominantly inherited cancer. Nat Genet. 1995; 9(1):70-4. DOI: 10.1038/ng0195-70. View

18.

Hollstein M, Sidransky D, Vogelstein B, Harris C . p53 mutations in human cancers. Science. 1991; 253(5015):49-53. DOI: 10.1126/science.1905840. View

19.

Yamakawa K, Morita R, Takahashi E, Hori T, Ishikawa J, Nakamura Y . A detailed deletion mapping of the short arm of chromosome 3 in sporadic renal cell carcinoma. Cancer Res. 1991; 51(17):4707-11. View

20.

Liu M, Okada S . Induction of free radicals and tumors in the kidneys of Wistar rats by ferric ethylenediamine-N,N'-diacetate. Carcinogenesis. 1994; 15(12):2817-21. DOI: 10.1093/carcin/15.12.2817. View